Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05556902 · ClinicalTrials.gov registry record · NA

Therapeutic Mechanisms of Epidural Spinal Cord Stimulation

A NA study of Hypertension and Low Back Pain, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT05556902: Recruiting NA study of Hypertension and Low Back Pain, sponsored by University of Alabama at Birmingham.

NCT05556902 is a NA study of Hypertension and Low Back Pain that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 80 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05556902, a NA study of Hypertension and Low Back Pain, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study in patients undergoing routine care epidural spinal cord stimulation (SCS) is to determine 1) whether SCS reduces arterial blood pressure (BP) in patients which chronic low back pain and hypertension, 2) whether higher baseline BP (i.e., hypertension) predicts reductions in pain following SCS, and finally 3) whether different SCS waveforms elicits stimulus-evoked compound action potentials (ECAPs) in spinal cord and at the cortex (electroencephalography, and magnetoenchphalography).

Primary Outcome

The research team will assess systolic and diastolic blood pressure with an arm cuff.

Interventions

  • DEVICE Permanent Epidural Spinal Cord Stimulation

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2022-08-02
Est. Completion 2030-05-01
Phase NA
University of Alabama at Birmingham

1,160 total trials

What NCT05556902 shows while recruiting

NCT05556902 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Permanent Epidural Spinal Cord Stimulation is the first listed.

NCT05556902 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT05556902 about?

NCT05556902 is a clinical study titled "Therapeutic Mechanisms of Epidural Spinal Cord Stimulation". The purpose of this study in patients undergoing routine care epidural spinal cord stimulation (SCS) is to determine 1) whether SCS reduces arterial blood pressure (BP) in patients which chronic low back pain and hypertension, 2) whether higher baseline BP (i.e., hypertension) predicts reductions in...

What is the current status of trial NCT05556902?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-08-02. Estimated completion is 2030-05-01.

What conditions does trial NCT05556902 study?

This clinical trial studies the following conditions: Hypertension, Low Back Pain, Blood Pressure.

What interventions are being tested in trial NCT05556902?

The interventions under investigation include: Permanent Epidural Spinal Cord Stimulation (DEVICE).

Who is sponsoring clinical trial NCT05556902?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05556902 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05556902's enrollment target sits among peer trials

80 316th of 470 higher than 150 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05556902, the US trial registry maintained by the National Library of Medicine. NCT05556902 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.